Fernand Labrie

Publications

Page 1 of 8, showing 50 records out of 360 total, starting on record 1, ending on 50

Publication Category Year
360. Samson, M., Labrie, F., Zouboulis, C.C., Luu-The, V. (2009) Biosynthesis of dihydrotestosterone by a pathway that does not require testosterone as intermediate in the SZ95 sebaceous gland cell line. J Invest Derm. 130:602-604 Prostate Cancer 2010
359. Bydal, P., Luu-The, V., Labrie, F., Poirier, D. (2009) Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: Chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities. Eur J Med Chem.44:632-644.

Attached files:
Bydal(2009)Steroidal lactone as inhibitors....pdf
Prostate Cancer 2009
358. Spitz, I.M., Chertin, B., Fridmans, A., Farkas, A., Bélanger, A., Hartman, H., Labrie, F. (2009). Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonists. Prostate Cancer Prostatic Dis, 12: 100-103.

Attached files:
SpitzIM(2009)Partiel androgen suppression.....pdf
Prostate Cancer 2009
357. Labrie, F., Cusan, L., Gomez, J.L., Martel, C., Bérubé, R., Bélanger, P., Bélanger, A., Vandenput, L., Mellström, D., Ohlsson, C. (2009) Comparable Amounts of Sex Steroids are Made Outside the Gonads in Men and Women: Strong Lesson for Hormone Therapy of Prostate and Breast Cancer, JSBMB, 113: 52-56.

Attached files:
LabrieF(2009)Comparable amounts of sex.....pdf
Prostate Cancer 2009
356. Ma, C., Yoshioka, M., Boivin, A., Gan, L, Takase, Y, Labrie, F., St-Amand, J. (2009) Atlas of dihydrotestosterone actions on the transcriptome of prostate in vivo. The Prostate, 69: 293-316

Attached files:
Ma C et al.(2009)Atlas of dihydrotestosterone....pdf
Prostate Cancer 2009
355. Lévesque, M.H., El-Alfy, M., Cusan, L., Labrie, F. (2009) Androgen receptor as a potential sign of prostate cancer metastasis, The Prostate, 69: 1704-1711.

Attached files:
LevesqueMH(2009)Androgen receptor.....pdf
Prostate Cancer 2009
354. Labrie, F. (2008) Preface. Best Pract Res Clin Endocrinol Metab, 22: pp. vii-ix.

Attached files:
LabrieF(2008)Preface Best Practice & Res....pdf
Prostate Cancer 2008
353. Luu-The, V., Bélanger, A., Labrie, F. (2008) Androgen biosynthetic pathways in the human prostate. Best Pract Res Clin Endocrinol Metab, 22: 207-221.

Attached files:
Luu-TheV(2008)Androgen biosynthetic....pdf
Prostate Cancer 2008
352. Ma, C., Yoshioka, M., Boivin, A., Belleau, P., Gan, L., Takase, Y., Labrie, F., St-Amand, J. (2008) Prostate specific genes and their regulation by dihydrotestosterone. Prostate, 68: 241-254.

Attached files:
MaC(2008)Prostate-specific genes and.pdf
Prostate Cancer 2008
351. Labrie, F., Koutsilieris, M. (2008) The 12th International Congress on Hormonal Steroids and Hormones & Cancer. J Steroid Biochem Mol Biol, 108: 179.

Attached files:
LabrieF(2008)KoutsilierisM-PrefaceJSBMB 108 p179.pdf
Prostate Cancer 2008
350. Ma, C., Yoshioka, M., Boivin, A., Belleau, P., Gan, L., Takase, Y., Labrie, F., St-Amand, J. (2008) Erratum: Prostate specific genes and their regulation by dihydrotestosterone. Prostate, 68: 1372.

Attached files:
MaC(2008)Erratum Prostate specific genes and.pdf
Prostate Cancer 2008
349. Labrie, F. (2008) Comment to: Prostate specific antigen (PSA)-based screening. Int J Urol, 15: 757-762.

Attached files:
LabrieF(2008)Comment to Prostate specific antigen....pdf
Prostate Cancer 2008
348. Akaza, H., Labrie, F., Namiki, M. (2007) [A way of thinking of a MAB therapy for local/locally advanced prostate cancer: the theory and recent evaluation]. Gan To Kagaku Ryoho. Jpn J Cancer Chemotherapy, 34: 657-669.

Attached files:
AkazaH(2007)Article Japonais-Jpn J Cancer Chemother.pdf
Prostate Cancer 2007
347. Cantin, L., Faucher, F., Couture, J.F., de Jésus, K.P., Legrand, P., Ciobanu, L., Fréchette, Y., Labrecque, R., Singh, S.M., Labrie, F., Breton, R. (2007) Structural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally-designed steroidal ligand bearing a bulky chain directed toward helix 12. J Biol Chem, 282: 30910-9.

Attached files:
CantinL(2007)Structural characterization of.....pdf
Prostate Cancer 2007
346. Labrie, F. (2007) Multiple intracrine hormonal targets in the prostate: oportunities and challenges. BJU Int, 100: 48-51.

Attached files:
LabrieF(2007)Multiple intracrine hormonal....pdf
Prostate Cancer 2007
345. Levesque, M.H., El-Alfy, M., Berger, L., Labrie, F., Labrie, C. (2007) Evaluation of AIbZIP and Cdc47 as Markers for Human Prostatic Diseases. Urology, 69: 196-201.

Attached files:
LevesqueMH(2007)Evaluation of albZIP and....pdf
Prostate Cancer 2007
344. Roy, J., Breton, R., Martel, C., Labrie, F., Poirier, D. (2007) Chemical synthesis and biological activities of 16α-derivatives of 5α-androstane-3α, 17 β-diol as antiandrogens. Bioorg Med Chem, 15: 3003-3018.

Attached files:
RoyJ(2007)Chemical synthesis and biol....pdf
Prostate Cancer 2007
343. Suzuki, K., Nishiyama, T., Hara, N., Yamana, K., Takahashi, K., Labrie, F. (2007) Importance of the intracrine metabolism of adrenal androgens in androgen-dependent prostate cancer. Prostate Cancer Prostatic Dis., 10: 301-6.

Attached files:
SuzukiK(2007)Importance of the intacrine.....pdf
Prostate Cancer 2007
342. Swanson, C., Mellström, D., Lorentzon, M., Vanderput, L., Jakobsson, J., Rane, A., Karlsson, M., Ljunggren, O., Smith, U., Eriksson, A.E., Bélanger, A., Labrie, F., Ohlsson, C. (2007) The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men. J Clin Endocrinol Metab, 92: 4878-4882.

Attached files:
SwansonC(2007)The uridine diphosphate.pdf
Prostate Cancer 2007
341. Takase, Y., Luu-The, V., Poisson-Paré, D., Labrie, F., Pelletier, G. (2007) Expression of sulfotransferase 1E1 in human prostate as studied by in situ hybridization and immunocytochemistry. Prostate, 67: 405-409.

Attached files:
TakaseY(2007)Expression of sulfotransferase....pdf
Prostate Cancer 2007
340. Tenta, R., Katopodis, H., Chatzïioannou, A., Pilalis, E., Calvo, E., Luu-The, V., Labrie, F., Kolisis, F., Koutsilieris, M. (2007) Microarray analysis of survival pathways in human PC-3 prostate cancer cells. Cancer Genomics Proteomics, 4: 309-18.

Attached files:
TentaR(2007)Microarray analysis of survival.....pdf
Prostate Cancer 2007
339. Vandenput, L., Labrie, F., Mellström, D., Swanson, C., Knutsson, T., Peeker, R., Ljunggren, O., Orwoll, E., Eriksson, A.L., Johnell, O., Damber, J.E., Ohlsson, C. (2007) Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men. J. of Bone and Mineral Research: The Official Journal of the American Soc. for Bone and Mineral Research, 22: 220-7.

Attached files:
VandenputL(2007)Serum levels of specfic.pdf
Prostate Cancer 2007
338. Candas, B., Labrie, F., Gomez, J.L., Cusan, L., Chevrette, E., Levesque, J., Brousseau, G. (2006) Relationship among initial serum prostate specific antigen, prostate specific antigen progression and prostate cancer detection at repeat screening visits. J Urol, 175: 510-517.

Attached files:
CandasB(2006)Relationship among initial serum....pdf
Prostate Cancer 2006
337. Labrie, F. (2006) Keyrole of endocrinology in the victory against prostate cancer. Bull. Cancer, 93: 949-58.

Attached files:
LabrieF(2006)Role cle de l'endo...Bull Cancer.pdf
Prostate Cancer 2006
336. Perreira De Jésus, K., Côté, P.L., Cantin, L., Blanchet, J., Labrie, F., Breton, R. (2006) Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity. Protein Science: a publication of the Protein Society, 15: 987-99.

Attached files:
PereiraDeJesusK(2006)Comparison of crystal structures of.....pdf
Prostate Cancer 2006
335. Takase, Y., Lévesque, M.H., Luu-The, V., El-Alfy, M., Labrie, F., Pelletier, G. (2006) Expression of enzymes involved in estrogen metabolism in human prostate. J.Histochem Cytochem., 54: 911-21.

Attached files:
TakaseY(2006)Expresison of enzymes involved....pdf
Prostate Cancer 2006
334. Labrie, F., Bélanger, A., Luu-The, V., Labrie, C., Simard, J., Cusan, L., Gomez, J., Candas, B. (2005) Gonadotropin-releasing hormone agonists in the treatment of prostate cancer. Endocrine Reviews, 26: 361-379.

Attached files:
LabrieF(2005)Gonadotropin-releasing..pdf
Prostate Cancer 2005
333. Labrie, F., Luu-The, V., Bélanger, A., Lin, S.-X., Simard, J., Pelletier, G., Labrie, C. (2005) Is DHEA a hormone? Starling Review. J Endocrinol, 187: 169-196.

Attached files:
LabrieF(2005)Is DHEA a hormone....pdf
Prostate Cancer 2005
332. Labrie, F. (2004) Current status of endocrine therapy in localized prostate cancer: cure has become a strong possibility. Brazilian J Urol, 30: 3-12.

Attached files:
LabrieF(2004)Current status of endocrine therapy.....pdf
Prostate Cancer 2004
331. Labrie, F. (2004) Major role of androgen blockade in the success of prostate cancer treatment: cure has become a very good possibility. Prostate Cancer Communication Newsletter, 20: 3-11.

Attached files:
LabrieF(2004)Major role of androgen blockade in the success.....pdf
Prostate Cancer 2004
330. Labrie, F. (2004) Medical castration with LHRH agonists: 25 years later with major benefits achieved on survival in prostate cancer. J Androl, 25: 305-313.

Attached files:
LabrieF(2004)Medical castration wiht LHRH agonists.....pdf
Prostate Cancer 2004
329. Labrie, F. (2004) Status of androgen blockade in prostate cancer in 2003, in: Koutsilieris, M. et Labrie, F., eds: Prostate cancer: Understanding the pathophysiology and re-designing a therapeutic approach, Athens, Greece, Paschalidis Medical Publications, pp 157-170.

Attached files:
LabrieF(2004)Status of androgen blockade in prostate cancer.....pdf
Prostate Cancer 2004
328. Labrie, F., Candas, B., Cusan, L., Gomez, J.L., Bélanger, A., Brousseau, G., Lévesque, J. (2004) Screening decreases prostate cancer mortality: 11-year follow-up on the 1988 Quebec prospective randomized controlled trial. The Prostate, 59: 311-318.

Attached files:
LabrieF(2004)Screening decreases prostate.....pdf
Prostate Cancer 2004
327. Labrie, F., Candas, B., Cusan, L., Gomez, J.L., Lévesque, J., Chevrette, E., Brousseau, G. (2004) Prostate Cancer Screening and Early Treatment: The Only Possibility for a Major Impact on Survival in Prostate Cancer, in: Labrie, F. et Koutsilieris, M., eds: Prostate Cancer: Understanding the pathophysiology and re-designing a therapeutic approach, Athens, Greece, Paschalidis Medical Publications, pp 67-78.

Attached files:
LabrieF(2004)Prostate Cancer screening and early.....pdf
Prostate Cancer 2004
326. Labrie, F., Cusan, L., Gomez, J., Luu-The, V., Candas, B., Bélanger, A., Labrie, C. (2004) Major impact of hormonal therapy in localized prostate cancer - death can already be an exception. JSBMB, 92: 327-344.

Attached files:
LabrieF(2004)Major impact of hormonal therapy in....pdf
Prostate Cancer 2004
325. Qiu, W., Zhou, M., Labrie, F., Lin, S.-X. (2004) Crystal structures of the multi-specific 17β-hydroxysteroid dehydrogenase type 5: Critical androgen regulation in human peripheral tissues. Mol Endocrinol, 18: 1798-1807.

Attached files:
QuiW(2004)Crystal structures of the multispecific.....pdf
Prostate Cancer 2004
324. Simard, J., Dumont, M., Soucy, P., Labrie, F., Tavtigian, S.V. (2004) Prostate Cancer Susceptibility Genes, in: Labrie, F. et Koutsilieris, M., eds: Prostate Cancer: Understanding the pathophysiology and re-designing a therapeutic approach, Athens, Greece, Paschalidis Medical Publications, pp 1-38.

Attached files:
SimardJ(2004)Prostate cancer susceptibility genes.....pdf
Prostate Cancer 2004
323. Labrie, F. (2003) Hormonal therapy in the management of prostate cancer at all stages of the disease, in: Syrigos, K.N., ed. Prostate Cancer: Biology, Diagnosis and Management, London, UK, Oxford University Press, pp 301-314.

Attached files:
LabrieF(2003)Hormonal therapy in the management of prostate cancer.....pdf
Prostate Cancer 2003
322. Labrie, F., Cusan, L., Gomez, J.L., Candas, B., Bélanger, A., Luu-The, V., Simard, J. (2003) De la biologie à la clinique: le décès dû au cancer de la prostate peut-il maintenant être une exception? Médecine/Sciences, 19: 910-19.

Attached files:
LabrieF(2003)De la biologie a la clinique.....pdf
Prostate Cancer 2003
321. Simard, J., Dumont, M., Labuda, D., Sinnett, D., Meloche, C., El Alfy, M., Berger, L., Lees, E., Labrie, F., Tavtigian, S.V. (2003) Prostate cancer susceptibility genes: lessons learned and challenges posed. Endocrine Related Cancer, 10: 225-259.

Attached files:
SimardJ(2003)Prostate cancer susceptibility genes.....pdf
Prostate Cancer 2003
320. Labrie, F. (2002) Androgen blockade in prostate cancer in 2002: major benefits on survival in localized disease. Mol Cell Endocrinol, 198: 77-87.

Attached files:
LabrieF(2002)Androgen blockade in prostate.....pdf
Prostate Cancer 2002
319. Labrie, F. (2002) Endocrine-sensitive cancers of the prostate and breast, in: Baster, J., Melmed, S. et New, M., eds: Genetics in Endocrinology, Lippincott-William and Wilkins, pp 607-661.

Attached files:
LabrieF(2002)Endocrine-Sensitive cancer of the .....pdf
Prostate Cancer 2002
318. Labrie, F., Candas, B., Gomez, L.J., Cusan, L. (2002) Can combined androgen blockade provide long term control or possible cure of localized prostate cancer? Urology, 60: 115-119.

Attached files:
LabrieF(2002)Can combined androgen blockade.....pdf
Prostate Cancer 2002
317. Crawford, E.D., Miller, G., Labrie, F., Hirano, D., Batuello, J., Globe, M. (2001) Prostate cancer pathology, screening and epidemiology. Reviews in Urology, 3: S2-S10.

Attached files:
CrawfordED(2001)Prostate cancer pathology......pdf
Prostate Cancer 2001
316. Gomella, L.G., Labrie, F., Gamito, E.J., Brawer, M.K. (2001) Prostate cancer: risk assessment and diagnostic approaches. Reviews in Urology, 3: S31-S38.

Attached files:
GomellaLG(2001)Prostate cancer Risk assessment and......pdf
Prostate Cancer 2001
315. Labrie, F. (2001) Le cancer de la prostate: blocage combiné des androgènes comme traitement à tous les stades de la maladie. Oncologie, 3: 3-12.

Attached files:
LabrieF(2001)Le cancer de la prostate blocage combine.....pdf
Prostate Cancer 2001
314. Labrie, F., Candas, B., Cusan, L., Gomez, J.L. (2001) The Laval University screening trial results (Chapter 17), in: Thompson, I.M., Resnick, M.I. et Klein, E.A., eds: Current Clinical Urology, Prostate Cancer Screening, Totowa, NJ, Humana Press Inc., pp 255-279.

Attached files:
LabrieF(2001)The Laval University screening trial......pdf
Prostate Cancer 2001
313. Labrie, F., Luu-The, V., Labrie, C., Simard, J. (2001) DHEA and its transformation into androgens and estrogens in peripheral target tissues: Intracrinology. Neuroendocrinologie, 22: 185-212.

Attached files:
LabrieF(2001)DHEA and its transformation into ........pdf
Prostate Cancer 2001
312. Pelletier, G., Luu-The, V., El Alfy, M., Li, S., Labrie, F. (2001) Immunoelectron microscopic localization of 3β-hydroxysteroid dehydrogenase and type 5 17β-hydroxysteroid dehydrogenase in the human prostate and mammary gland. J. Mol. Endocrinol., 26: 11-19.

Attached files:
PelletierG(2001)Immunoelectron microscopic localization of 3beta ....pdf
Prostate Cancer 2001
311. Roach III, M.J., Thrasher, J.B., Blasko, J., Raben, D., Stone, N., Katz, A., Labrie, F. (2001) Prostatectomy, brachytherapy, intensity modulated radiotherapy, hormonal-radiotherapy, salvae cryosurgery and the role of combined hormonal blokade in the treatment of prostate cancer. Reviews in Urology, 3: S49-S58.

Attached files:
RoachMIII(2001)Prostatectomy brachytherapy ......pdf
Prostate Cancer 2001
<< previous
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 next >>

Biography  |  Publications  |  Scientific Conferences  |  Selected Slide Presentations  |  Awards